Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety Study of 4975 in Patients Undergoing Total Hip Replacement

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Key Inclusion Criteria:~* Male or female aged 18 to 85 years with an American Society of Anesthesiologists (ASA) status of I, II, III~* Planning to undergo unilateral THA~* In good health and capable of undergoing THA with spinal block and sedation anesthesia~* No additional planned surgeries during the course of the trial~* Willing and able to complete the study procedures and pain scales and to communicate meaningfully in English~Key Exclusion Criteria:~* A body mass index greater than 40~* Known bleeding disorder or is taking agents affecting coagulation preoperatively~* A medical condition that could adversely impact the patient's participation, safety, or conduct of the study~* Diabetes mellitus with a known HbA1C\>9.5 or a history of prolonged uncontrolled diabetes~* Previous hip arthroplasty of the same hip~* Participated in another clinical trial within 30 days of the planned hip surgery

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Study treatment, 4975, is instilled directly into surgical site
- 2 (Type: PLACEBO_COMPARATOR): Placebo is instilled directly into surgical site

Based on this trial design, predict the completion outcome and termination type (if applicable).